From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

MGC Pharmaceuticals – do the maths dummies, I'm 99.2% ahead on this bear call and it is going to go from £15m now to zero

By Tom Winnifrith | Wednesday 31 January 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


On November 1 2022, I published a red flags dossier on Turner Pope spoof MGC Pharmaceuticals (MXC) with the shares at 2.25p giving market cap of £70 million. Wind forward 15 months and after a 1000 for 1 consolidation the shares are 18p meaning that those who mocked my advice have lost 99.2% of their hard earned. But so many gazillion pieces of worthless confetti have been issued that the market cap is still £15 million and today’s quarterlies suggest that is way too high as yet another cash crisis looms.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Black-Swan

Video: Poking Bears And Black Swans

 

SBTX

Is Stuart Ashman lying again?

 

Crime-Scene

So farewell then MichaelWalters.com

Time left: 14:52:45